The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 17, 2026
Snapshot (as of Jul 17, 2026): Abbott Laboratories (ABT) pays a $2.48 annual dividend ($0.63 quarterly), yielding 2.51% at $98.82/share. Next ex-dividend date 2026-07-15. 12 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.51%
Annual Dividend: $2.48 per share
Payout Ratio: 66.7%
Ex-Dividend Date: 2026-07-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 44
Abbott Laboratories dividend has been a fixture in healthcare income portfolios for decades, backed by a business spanning medical devices, diagnostics, nutrition, and pharmaceuticals. ABT currently pays $2.44 per share annually, distributed quarterly, with the next ex-dividend date on July 15, 2026. The current yield sits at 2.6%. With a beta of 0.62, ABT stock carries meaningfully lower price volatility than the broader market, which suits income investors who prioritize steadiness over maximum yield.
Abbott Laboratories pays out 66.7% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a diversified revenue base spanning essential healthcare categories: point-of-care diagnostics, cardiovascular devices, pediatric and adult nutrition, and a broad portfolio of established pharmaceuticals. Abbott Laboratories dividend safety is worth examining in light of that payout, since 66.7% leaves a narrower cushion than lower-ratio peers, and any earnings pressure from a single segment could test the dividend's headroom.
Abbott Laboratories dividend history shows a CAGR of 7.3% per year from 2010 to 2025. Per-share payments grew from $0.8252 to $2.36 over that span (2026 is a partial year and excluded from the rate calculation). The largest single-year increase in the window was 25.0% in 2021, though the data also contains at least one year-over-year decline exceeding 5%, so growth has not been perfectly linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.9% | $1.88 (2022) | $2.36 (2025) |
| 5-Year | +10.4% | $1.44 (2020) | $2.36 (2025) |
| 10-Year | +9.4% | $0.96 (2015) | $2.36 (2025) |
ABT fits dividend investors who want healthcare sector exposure with moderate income and a growth-oriented payout history. The current yield of 2.6% falls in the moderate (2–4%) range and sits above the 5-year average of 2.19%, meaning today's entry point offers a slightly richer income rate than the recent norm. Twelve consecutive years of dividend increases reflect a commitment to growing the payout, and the 7.3% annual CAGR over 15 years is real. The trade-off is a payout ratio of 66.7%, which is elevated and leaves less room for error if earnings soften. Investors get a growing dividend from a diversified healthcare business; they accept a payout ratio that is not conservative.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-15 | $0.6300 |
| 2026-04-15 | $0.6300 |
| 2026-01-15 | $0.6300 |
| 2025-10-15 | $0.5900 |
| 2025-07-15 | $0.5900 |
| 2025-04-15 | $0.5900 |
| 2025-01-15 | $0.5900 |
| 2024-10-15 | $0.5500 |
| 2024-07-15 | $0.5500 |
| 2024-04-12 | $0.5500 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.8900 |
| 2025 | $2.3600 |
| 2024 | $2.2000 |
| 2023 | $2.0400 |
| 2022 | $1.8800 |
Project income from ABT with the ABT dividend calculator or track your full portfolio with the dividend tracker.